Clinical Trials Browser

INDUSTRY × Carcinoma, Non-Small-Cell Lung × Topotecan × Clear all

NCT04022876 2022-10-10

A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT00065182 2019-06-24

Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer

Phase 2 Completed

399 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00390806 2014-01-20

Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

Phase 3 Completed

472 enrolled 35 charts

Carcinoma, Non-Small-Cell Lung

NCT00049998 2013-03-04

Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung